EAM
AMPE

Empery Asset Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Empery Asset Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-14,208
Closed -$2.43M – 90
2021
Q4 		$2.43M Buy
+14,208
New +$5.3M 5.07% 6

Other funds holding AMPE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $1.83B AUM 15.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

Empery Asset Management's AMPE Position: Q1 2022 in Review

Empery Asset Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q1 2022, closing a stake of 14,208 shares — an estimated $2.43M sold.

Empery Asset Management first reported a position in AMPE in Q4 2021 and held it in 1 quarter. The position peaked at $2.43M in Q4 2021. 128 funds tracked by Wall St. Rank hold AMPE as of Q1 2022.

  • Empery Asset Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q1 2022 after selling out during the quarter.
  • Empery Asset Management sold 14,208 Ampio Pharmaceuticals Inc. shares in Q1 2022, an estimated $2.43M.
  • Empery Asset Management first reported a position in Ampio Pharmaceuticals Inc. in Q4 2021 and held it in 1 quarter.
  • Empery Asset Management's Ampio Pharmaceuticals Inc. position peaked at $2.43M in Q4 2021.
  • 128 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2022.

Based on Empery Asset Management's 13F filing for Q1 2022, filed 16 May 2022.